NATIONAL INSTITUTES OF HEALTH
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia
- Conditions
- Deglutition Disorders
- First Posted Date
- 2003-05-02
- Last Posted Date
- 2010-01-13
- Target Recruit Count
- 204
- Registration Number
- NCT00059670
- Locations
- 🇺🇸
Medical College University of Wisconsin, Milwaukee, Wisconsin, United States
Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis
- Conditions
- Premature BirthNecrotizing Enterocolitis
- First Posted Date
- 2003-04-29
- Last Posted Date
- 2010-01-13
- Target Recruit Count
- 372
- Registration Number
- NCT00059449
- Locations
- 🇺🇸
University Hospital, Cincinnati, Ohio, United States
🇺🇸Good Samaritan Hospital, Cincinnati, Ohio, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
- First Posted Date
- 2003-04-28
- Last Posted Date
- 2012-10-23
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 138
- Registration Number
- NCT00059475
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States
Hepatitis C: Grading and Staging by MR
- Conditions
- Hepatitis
- First Posted Date
- 2003-04-25
- Last Posted Date
- 2010-03-18
- Target Recruit Count
- 80
- Registration Number
- NCT00059397
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
Prevention of Recurrent Hepatitis B After Liver Transplantation
- Conditions
- Hepatocellular CarcinomaHepatitis BCirrhosisAcute Liver Failure
- First Posted Date
- 2003-04-23
- Last Posted Date
- 2024-11-15
- Target Recruit Count
- 317
- Registration Number
- NCT00059267
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Differential Metabolism of Dietary Fatty Acids
- Conditions
- DiabetesHyperlipidemiaObesity
- Interventions
- Dietary Supplement: Oleic acid (OA)Dietary Supplement: Palmitic Acid (PA)
- First Posted Date
- 2003-04-23
- Last Posted Date
- 2017-10-12
- Target Recruit Count
- 19
- Registration Number
- NCT00059254
- Locations
- 🇺🇸
Utmb Gcrc, Galveston, Texas, United States
Trial of High-dose Urso in Primary Sclerosing Cholangitis
- Conditions
- Primary Sclerosing Cholangitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2003-04-22
- Last Posted Date
- 2021-05-03
- Target Recruit Count
- 150
- Registration Number
- NCT00059202
- Locations
- 🇺🇸
St. Louis University, Saint Louis, Missouri, United States
🇺🇸Medical College of Virginia, Richmond, Virginia, United States
🇺🇸University of Washington, Seattle, Washington, United States
Gabapentin to Treat Itch in Patients With Liver Disease
- Conditions
- PruritusLiver DiseaseItchingCirrhosisCholestasis
- Interventions
- Drug: Placebo
- First Posted Date
- 2003-04-16
- Last Posted Date
- 2017-10-13
- Target Recruit Count
- 15
- Registration Number
- NCT00058890
- Locations
- 🇺🇸
Columbia University College of Physicians and Surgeons, New York, New York, United States
Treatment of Cholestatic Pruritus With Sertraline
- Conditions
- Hepatitis CLiver Cirrhosis, BiliaryPruritus
- First Posted Date
- 2003-04-16
- Last Posted Date
- 2010-01-13
- Target Recruit Count
- 40
- Registration Number
- NCT00058903
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
Anidulafungin Versus Fluconazole in the Treatment of Candidemia
- Conditions
- CandidaCandidiasis
- First Posted Date
- 2003-04-11
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 248
- Registration Number
- NCT00058682
- Locations
- 🇺🇸
National Cancer Institute (NCI), Bethesda, Maryland, United States